Mirae Asset Global Investments
LYEL icon

Mirae Asset Global Investments’s Lyell Immunopharma LYEL Stock Holding History

Mirae Asset Global Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Sell
1,044
-64
-6% -$1.16K ﹤0.01% 1522
2026
Q1 		$22.2K Buy
1,108
+77
+7% +$1.8K ﹤0.01% 1417
2025
Q4 		$31.7K Buy
1,031
+288
+39% +$6.45K ﹤0.01% 1477
2025
Q3 		$12.1K Buy
743
+173
+30% +$1.98K ﹤0.01% 1551
2025
Q2 		$5.04K Buy
570
+81
+17% +$738 ﹤0.01% 1540
2025
Q1 		$5.29K Buy
489
+24
+5% +$294 ﹤0.01% 1513
2024
Q4 		$6.05K Buy
465
+2
+0.4% +$40 ﹤0.01% 1547
2024
Q3 		$14K Buy
463
+82
+22% +$2.41K ﹤0.01% 1477
2024
Q2 		$10.5K Buy
+381
New +$18.1K ﹤0.01% 1460
2024
Q1 		– Sell
-11,275
Closed -$437K – 2570
2023
Q4 		$437K Buy
11,275
+10,297
+1,053% +$371K ﹤0.01% 2028
2023
Q3 		$28.8K Buy
978
+139
+17% +$6.6K ﹤0.01% 2561
2023
Q2 		$52.8K Sell
839
-428
-34% -$23.7K ﹤0.01% 2590
2023
Q1 		$59.8K Sell
1,267
-3,311
-72% -$177K ﹤0.01% 2501
2022
Q4 		$318K Buy
4,578
+6
+0.1% +$596 ﹤0.01% 2128
2022
Q3 		$670K Buy
4,572
+2,151
+89% +$291K ﹤0.01% 1712
2022
Q2 		$316K Buy
+2,421
New +$247K ﹤0.01% 1961

Other funds holding LYEL

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Mirae Asset Global Investments's LYEL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Lyell Immunopharma (LYEL) stake by 5.8% in Q2 2026, selling an estimated $1.16K and leaving 1,044 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Mirae Asset Global Investments first reported a position in LYEL in Q2 2022 and has held it in 16 quarters since. The position peaked at $670K in Q3 2022. 8 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Mirae Asset Global Investments held 1,044 shares of Lyell Immunopharma worth $14.7K as of Q2 2026.
  • Mirae Asset Global Investments sold 64 Lyell Immunopharma shares in Q2 2026, an estimated $1.16K.
  • Lyell Immunopharma made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1522 holding.
  • Mirae Asset Global Investments first reported a position in Lyell Immunopharma in Q2 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Lyell Immunopharma position peaked at $670K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.